封面
市場調查報告書
商品編碼
1629252

神經遺傳學測試市場,按測試類型、技術、應用、最終用戶、國家和地區 - 2025-2032 年全球行業分析、市場規模、市場佔有率和預測

Neurogenetic Testing Market, By Test Type, By Technology, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 355 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2024 年神經遺傳學測試市場規模為 7.8625 億美元,2025 年至 2032 年複合年成長率為 12.2%。

神經遺傳學測試市場-市場動態

神經系統疾病管理中對個人化醫療的需求不斷增加。

神經系統疾病管理中對個人化醫療日益成長的需求是神經遺傳學檢測市場的關鍵驅動力。個人化醫療根據個人基因圖譜客製化治療方案,從而實現更精確、更有效的干涉措施。由於阿茲海默症、帕金森氏症和亨廷頓舞蹈症等神經系統疾病受到遺傳因素的影響,了解患者的基因組成有助於確定最合適的治療方法。這種方法減少了試誤方法,改善了患者的治療結果。醫療保健提供者和患者越來越認知到個人化醫療的好處,導致基因檢測得到更廣泛的採用。隨著醫療保健產業朝著更有針對性和個人化的照護方向發展,對神經遺傳學檢測的需求預計將會成長,從而推動神經系統疾病的精準治療。

神經遺傳學測試市場 - 關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2025-2032 年)每年將以 12.2% 左右的複合年成長率成長

根據測試類型細分,預計產前基因檢測將在 2024 年顯示最大的市場佔有率

從技術細分來看,二代定序(NGS)是2024年的領先技術

根據應用細分,阿茲海默症是 2024 年的領先應用

按地區分類,北美是 2024 年的主要收入來源

神經遺傳學測試市場-細分分析:

全球神經遺傳學測試市場根據測試類型、技術、應用、最終用戶和地區進行細分。

根據測試類型,市場分為三類:產前基因測試、帶因者篩檢、診斷測試和預測測試。產前基因檢測是神經遺傳學檢測市場中最突出的部分。由於人們對未出生兒童遺傳性疾病的早期檢測的認知和需求不斷提高,該細分市場獲得了巨大的關注。產前檢測有助於識別唐氏症、囊性纖維化和其他神經系統疾病等遺傳疾病,為準父母提供有價值的資訊。非侵入性產前檢測 (NIPT) 的興起和技術的進步使這些檢測變得更加容易和準確。隨著人們對早期疾病預防的日益關注,產前基因檢測被廣泛採用,推動了市場的成長。該細分市場預計將保持其突出地位,特別是隨著下一代定序(NGS)技術的不斷進步,該技術提高了測試準確性並降低了與傳統測試方法相關的風險。

根據技術,市場分為兩類:次世代定序(NGS)、聚合酶鏈反應(PCR)、微陣列和螢光原位雜合技術(FISH)等。下一代定序(NGS)是神經遺傳學測試市場中最突出的技術。 NGS 可對遺傳物質進行高通量、準確且高效的分析,使其成為識別與基因突變相關的神經系統疾病的強大工具。它能夠在短時間內對大量基因資料進行測序,這徹底改變了基因測試,特別是在診斷阿茲海默症、帕金森氏症和亨廷頓舞蹈症等複雜的神經系統疾病方面。 NGS 提供了對遺傳變異和突變的詳細見解,這對於個人化治療方法至關重要。 NGS 的成本效益、高精度以及對精準醫療日益成長的需求推動了 NGS 的日益普及。隨著不斷進步,NGS有望保持其主導地位,並在未來的神經遺傳學診斷中發揮核心作用。

神經遺傳學測試市場-地理洞察

北美是神經遺傳學檢測市場的領先地區,這主要歸功於先進的醫療基礎設施、對基因檢測的高度認知以及重要公司的強大影響力。美國是主要貢獻者,廣泛採用基因檢測並在神經系統疾病方面進行了強力的研究。在個人化醫療日益受到關注以及政府對基因研究的資助不斷增加的推動下,歐洲緊隨其後。亞太地區也出現了顯著成長,特別是在中國和印度等國家,醫療保健系統的改善和基因檢測意識的提高正在刺激需求。此外,由於醫療保健投資的增加和醫療保健需求的增加,拉丁美洲和中東逐漸成為潛在市場。

在美國,先進的醫療基礎設施、基因檢測的廣泛採用以及對個人化醫療的高度重視推動了神經遺傳學檢測市場的發展。領先公司和研究機構的存在,以及政府支持基因研究的舉措,促進了該市場的快速成長和創新。

神經遺傳學測試市場-競爭格局:

神經遺傳學檢測市場的競爭格局是由成熟的診斷巨頭和專業基因檢測公司共同塑造的。 Illumina、Thermo Fisher Scientific 和 Quest Diagnostics 等公司憑藉廣泛的基因檢測產品組合和強大的分銷網路佔據主導地位。 Fulgent Genetics 和 GeneDx 等較小的公司專注於專業檢測服務,利用下一代定序等創新技術為神經系統疾病提供精確診斷。市場也見證了基因檢測公司和醫療保健提供者之間的合作不斷增加,從而提高了檢測的可及性。隨著個人化醫療需求的不斷成長,參與者正在投資擴大基因檢測能力並整合人工智慧以改善檢測結果。競爭壓力鼓勵持續創新,使市場充滿活力,新進業者在快速發展的神經遺傳學測試領域探索尚未開發的機會。

最新進展:

2024 年 2 月,希森美康公司和日立高新技術公司宣布合作開發利用毛細管電泳定序儀(CE 定序儀)的基因檢測系統。這項合作關係旨在擴大其在未開發經濟體中的影響力。

目錄

第1章:神經遺傳學測試市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 按測試類型分類的神經遺傳學測試市場片段
    • 神經遺傳學測試市場技術片段
    • 神經遺傳學測試市場片段(按應用)
    • 最終用戶的神經遺傳學測試市場片段
    • 按國家/地區分類的神經遺傳學測試市場片段
    • 按地區分類的神經遺傳學測試市場片段
  • 競爭洞察

第 3 章:神經遺傳學測試主要市場趨勢

  • 神經遺傳學測試市場促進因素
    • 市場促進因素的影響分析
  • 神經遺傳學測試市場限制
    • 市場限制影響分析
  • 神經遺傳學測試市場機會
  • 神經遺傳學測試市場未來趨勢

第 4 章:神經遺傳學測試產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:神經遺傳學測試市場:地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第 6 章:神經遺傳學測試市場格局

  • 神經遺傳學測試市場佔有率分析,2024 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:神經遺傳學測試市場 - 按測試類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 產前基因檢測
    • 攜帶者篩選
    • 診斷測試
    • 預測測試

第 8 章:神經遺傳學測試市場 - 按技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 新一代定序 (NGS)
    • 聚合酶鍊式反應 (PCR)
    • 微陣列
    • 螢光原位雜合技術 (FISH)
    • 其他

第 9 章:神經遺傳學測試市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 阿茲海默症
    • 帕金森氏症
    • 亨丁頓舞蹈症
    • 癲癇
    • 多發性硬化症
    • 其他

第 10 章:神經遺傳學測試市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診斷實驗室
    • 研究所
    • 遺傳諮詢中心

第 11 章:神經遺傳學測試市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美神經遺傳學檢測主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按測試類型)
    • 北美市場規模和預測(按技術)
    • 北美市場規模和預測(按應用)
    • 北美市場規模和預測(按最終用戶)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲神經遺傳學測試主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模和預測(按測試類型)
    • 歐洲市場規模與預測(按技術)
    • 歐洲市場規模和預測(按應用)
    • 歐洲市場規模和預測(按最終用戶)
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區神經遺傳學檢測主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 按測試類型分類的亞太地區市場規模和預測
    • 按技術分類的亞太地區市場規模和預測
    • 亞太地區市場規模與預測(按應用)
    • 按最終用戶分類的亞太地區市場規模和預測
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲神經遺傳學測試主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模和預測(按測試類型)
    • 拉丁美洲市場規模與預測(按技術)
    • 拉丁美洲市場規模與預測(按應用)
    • 拉丁美洲市場規模和預測(按最終用戶)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲 (MEA)
    • 概述
    • 中東和非洲神經遺傳學檢測主要製造商
    • MEA 市場規模和預測(按國家/地區)
    • MEA 市場規模和預測(按測試類型)
    • MEA 市場規模和預測(按技術)
    • MEA 市場規模和預測(按應用)
    • MEA 市場規模和預測(按最終用戶)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章:主要供應商分析 - 神經遺傳學測試產業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • 23andMe
    • Invitae Corporation
    • Fulgent Genetics
    • Illumina
    • LabCorp
    • Quest Diagnostics
    • GeneDx
    • BioReference Laboratories
    • Arup Laboratories
    • Asuragen
    • Thermo Fisher Scientific
    • NextBio
    • NeoGenomics
    • Eurofins Scientific
    • Myriad Genetics
    • Centogene
    • Genetic Health Inc.

第 13 章:360 度分析師視角

第 14 章:附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4572

REPORT HIGHLIGHT

Neurogenetic Testing Market size was valued at US$ 786.25 Million in 2024, expanding at a CAGR of 12.2% from 2025 to 2032.

The neurogenetic testing market focuses on diagnostic tests that identify genetic variations linked to neurological disorders. These tests are crucial for diagnosing conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and various genetic neuropathies. Neurogenetic testing can help in understanding disease progression, selecting appropriate treatments, and predicting risk for family members. The market is driven by advances in genetic research, increasing awareness of personalized medicine, and growing demand for early disease detection. Technological advancements like next-generation sequencing (NGS) are enhancing the accuracy and efficiency of these tests. With a rise in genetic counseling services and healthcare's shift toward precision medicine, the demand for neurogenetic tests is expected to continue growing. The market also faces challenges related to ethical concerns, insurance coverage, and the need for regulation in testing practices.

Neurogenetic Testing Market- Market Dynamics

Increasing demand for personalized medicine in neurological disease management.

The growing demand for personalized medicine in neurological disease management is a key driver for the neurogenetic testing market. Personalized medicine tailors treatments based on individual genetic profiles, allowing for more precise and effective interventions. As neurological conditions like Alzheimer's, Parkinson's, and Huntington's disease are influenced by genetic factors, understanding a patient's genetic makeup helps identify the most suitable treatments. This approach reduces trial-and-error methods, improving patient outcomes. The increasing recognition of the benefits of personalized medicine among healthcare providers and patients has led to more widespread adoption of genetic testing. As the healthcare industry moves toward more targeted and individualized care, the demand for neurogenetic testing is expected to grow, advancing precision therapies for neurological disorders.

Neurogenetic Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.2% over the forecast period (2025-2032)

Based on Test Type segmentation, Prenatal Genetic Testing was predicted to show maximum market share in the year 2024

Based on Technology segmentation, Next-Generation Sequencing (NGS) was the leading Technology in 2024

Based on Application segmentation, Alzheimer's Disease was the leading Application in 2024

Based on region, North America was the leading revenue generator in 2024

Neurogenetic Testing Market- Segmentation Analysis:

The Global Neurogenetic Testing Market is segmented based on Test Type, Technology, Application, End-User, and Region.

The market is divided into three categories based on Test Type: Prenatal Genetic Testing, Carrier Screening, Diagnostic Testing, and Predictive Testing. Prenatal Genetic Testing is the most prominent segment in the neurogenetic testing market. This segment has gained significant traction due to increasing awareness and demand for early detection of genetic disorders in unborn children. Prenatal testing helps identify genetic conditions like Down syndrome, cystic fibrosis, and other neurological disorders, providing valuable information for expecting parents. The rise in non-invasive prenatal testing (NIPT) and advancements in technology have made these tests more accessible and accurate. With a growing focus on early disease prevention, prenatal genetic testing is being adopted widely, driving market growth. This segment is expected to maintain its prominence, particularly with the ongoing advancements in next-generation sequencing (NGS) technologies, which improve testing accuracy and reduce risks associated with traditional testing methods.

The market is divided into two categories based on Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, and Fluorescence in situ Hybridization (FISH), Others. Next-Generation Sequencing (NGS) is the most prominent technology in the neurogenetic testing market. NGS allows for high-throughput, accurate, and efficient analysis of genetic material, making it a powerful tool for identifying neurological disorders linked to genetic mutations. Its ability to sequence vast amounts of genetic data in a short time has revolutionized genetic testing, particularly in diagnosing complex neurological diseases like Alzheimer's, Parkinson's, and Huntington's disease. NGS provides detailed insights into genetic variations and mutations that are critical for personalized treatment approaches. The growing adoption of NGS is driven by its cost-effectiveness, high accuracy, and the increasing demand for precision medicine. With continuous advancements, NGS is expected to maintain its dominance and play a central role in the future of neurogenetic diagnostics.

Neurogenetic Testing Market- Geographical Insights

North America is the leading region in the neurogenetic testing market, primarily due to advanced healthcare infrastructure, high awareness about genetic testing, and a strong presence of key companies. The U.S. is a major contributor, with widespread adoption of genetic testing and robust research in neurological diseases. Europe follows closely, driven by the growing focus on personalized medicine and increasing government funding for genetic research. The Asia-Pacific region is also witnessing significant growth, particularly in countries like China and India, where improving healthcare systems and rising awareness about genetic testing are fueling demand. Additionally, Latin America and the Middle East are gradually emerging as potential markets due to increasing healthcare investments and rising healthcare needs.

In the United States, the neurogenetic testing market is driven by advanced healthcare infrastructure, widespread adoption of genetic testing, and a strong focus on personalized medicine. The presence of leading companies and research institutions, along with government initiatives supporting genetic research, contributes to the rapid growth and innovation in this market.

Neurogenetic Testing Market- Competitive Landscape:

The competitive landscape of the neurogenetic testing market is shaped by a mix of established diagnostic giants and specialized genetic testing firms. Companies like Illumina, Thermo Fisher Scientific, and Quest Diagnostics dominate with extensive genetic testing portfolios and strong distribution networks. Smaller players such as Fulgent Genetics and GeneDx focus on specialized testing services, leveraging innovative technologies like next-generation sequencing to offer precise diagnostics for neurological disorders. The market is also witnessing increasing collaboration between genetic testing firms and healthcare providers, enhancing the accessibility of testing. With the rising demand for personalized medicine, players are investing in expanding their genetic testing capabilities and integrating artificial intelligence for improved test results. The competitive pressure encourages continuous innovation, making the market highly dynamic, with new entrants exploring untapped opportunities in the rapidly evolving field of neurogenetic testing.

Recent Developments:

In February 2024, Sysmex Corporation and Hitachi High-Tech Corporation announced a collaboration to develop genetic testing systems utilizing capillary electrophoresis sequencers (CE sequencers). This partnership aims to expand its presence in untapped economies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROGENETIC TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 23andMe
  • Invitae Corporation
  • Fulgent Genetics
  • Illumina
  • LabCorp
  • Quest Diagnostics
  • GeneDx
  • BioReference Laboratories
  • Arup Laboratories
  • Asuragen
  • Thermo Fisher Scientific
  • NextBio
  • NeoGenomics
  • Eurofins Scientific
  • Myriad Genetics
  • Centogene
  • Genetic Health Inc.

GLOBAL NEUROGENETIC TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Prenatal Genetic Testing
  • Carrier Screening
  • Diagnostic Testing
  • Predictive Testing

GLOBAL NEUROGENETIC TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Fluorescence in situ Hybridization (FISH)
  • Others

GLOBAL NEUROGENETIC TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Alzheimer's Disease
  • Parkinson's Disease
  • Huntington's Disease
  • Epilepsy
  • Multiple Sclerosis
  • Others

GLOBAL NEUROGENETIC TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Genetic Counseling Center

GLOBAL NEUROGENETIC TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Neurogenetic Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Neurogenetic Testing Market Snippet by Test Type
    • 2.1.2. Neurogenetic Testing Market Snippet by Technology
    • 2.1.3. Neurogenetic Testing Market Snippet by Application
    • 2.1.4. Neurogenetic Testing Market Snippet by End-User
    • 2.1.5. Neurogenetic Testing Market Snippet by Country
    • 2.1.6. Neurogenetic Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Neurogenetic Testing Key Market Trends

  • 3.1. Neurogenetic Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Neurogenetic Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Neurogenetic Testing Market Opportunities
  • 3.4. Neurogenetic Testing Market Future Trends

4. Neurogenetic Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Neurogenetic Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Neurogenetic Testing Market Landscape

  • 6.1. Neurogenetic Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Neurogenetic Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Prenatal Genetic Testing
    • 7.1.3. Carrier Screening
    • 7.1.4. Diagnostic Testing
    • 7.1.5. Predictive Testing

8. Neurogenetic Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Next-Generation Sequencing (NGS)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Microarray
    • 8.1.5. Fluorescence in situ Hybridization (FISH)
    • 8.1.6. Others

9. Neurogenetic Testing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Alzheimer's Disease
    • 9.1.3. Parkinson's Disease
    • 9.1.4. Huntington's Disease
    • 9.1.5. Epilepsy
    • 9.1.6. Multiple Sclerosis
    • 9.1.7. Others

10. Neurogenetic Testing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Research Institutes
    • 10.1.5. Genetic Counseling Center

11. Neurogenetic Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Neurogenetic Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. The U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Neurogenetic Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Neurogenetic Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Neurogenetic Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Neurogenetic Testing Key Manufacturers in the Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Neurogenetic Testing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. 23andMe
    • 12.2.2. Invitae Corporation
    • 12.2.3. Fulgent Genetics
    • 12.2.4. Illumina
    • 12.2.5. LabCorp
    • 12.2.6. Quest Diagnostics
    • 12.2.7. GeneDx
    • 12.2.8. BioReference Laboratories
    • 12.2.9. Arup Laboratories
    • 12.2.10. Asuragen
    • 12.2.11. Thermo Fisher Scientific
    • 12.2.12. NextBio
    • 12.2.13. NeoGenomics
    • 12.2.14. Eurofins Scientific
    • 12.2.15. Myriad Genetics
    • 12.2.16. Centogene
    • 12.2.17. Genetic Health Inc.

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us